ALSA Ventures
Robert Balfour is a Director at Axovia Therapeutics, a company focused on researching and developing novel AAV gene therapies for ciliopathies. Robert is also a Director at Promatix Biosciences Ltd, where Robert serves as the Founding CEO. With a background in neurophysiology and physiology, Robert has extensive experience in the biotechnology and healthcare investment industry, holding various roles such as Investment Director at ALSA Ventures and Investment Manager at Inventages Venture Capital. Additionally, Robert has experience as Chief Business Officer at Viatem and as a Partner & Co-founder at Waimangu Ventures.